Adequacy of published oncology randomized controlled trials to provide therapeutic details needed for clinical application.
Explore this paper's citation graph
Summary
RCTs published in major oncology journals do not consistently report essential therapeutic details necessary for translation of the trial findings to clinical practice, and potential solutions to improve reporting include modification of submission guidelines, use of online appendices, and providing open access to trial protocols.
- Type
- article
- Published
- 2010-05-19
- Cited by
- 100
- References
- 13
- Access
- Open access
- OpenAlex
- https://openalex.org/W2118828017
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:27666160
Keywords
Medicine, Randomized controlled trial, Clinical trial, Dosing, Clinical Oncology
References
- The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
- Preventing medication errors in cancer chemotherapy.
- Translating guidelines into practice: a systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines
- CONSORT revised--improving the reporting of randomized trials.
- Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review.
- The quality oncology practice initiative: assessing and improving care within the medical oncology practice.
- Current status of administration of medicines.
- Requisitos uniformes para manuscritos submetidos a periódicos biomédicos: escrevendo e editando para publicações biomédicas
- Quality performance improvement with the implementation of standard chemotherapy order forms.
- Clinical Practice Guidelines in Oncology: Translating Evidence Into Practice (and back).
- A continuous-improvement approach for reducing the number of chemotherapy-related medication errors.
- Uniform Requirements for Manuscripts Submitted to Biomedical Journals
- [International Committee of Medical Journal Editors].
Cited by
- Horse versus rabbit antithymocyte globulin in aplastic anemia.
- Along with the privilege of authorship come important responsibilities
- Improving the reporting of behaviour change interventions
- Transparent Reporting of Trials Is Essential
- CONSORT 2010: progress and challenges
- A systematic review of the quality of reporting in published smoking cessation trials for pregnant women: an explanation for the evidence-practice gap?
- Reducing waste from incomplete or unusable reports of biomedical research.
- Reporting medical research
- How well do randomised controlled trials of physical interventions for people with spinal cord injury adhere to the CONSORT guidelines? An analysis of trials published over a 10-year period
- Real-world experience with adjuvant fec-d chemotherapy in four Ontario regional cancer centres.
- Refining a checklist for reporting patient populations and service characteristics in hospice and palliative care research.
- Improving the reporting of randomised trials: the CONSORT Statement and beyond
- Poor description of non-pharmacological interventions: analysis of consecutive sample of randomised trials
- Neue Arzneimittel in der Onkologie: Merkmale klinischer Zulassungsstudien und Argumente für die rasche Durchführung unabhängiger klinischer Studien nach der Zulassung
- [Improving the quality of randomized trials reports: a collaboration between authors, reviewers and editors].
- Uptake of novel medical therapies in the general population.
- Increasing value and reducing waste in biomedical research: who's listening?
- Reporting of interventions in randomised trials: an audit of journal Instructions to Authors
- Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumors.
- From quality of publication to quality of care: translating trials to practice.
Related papers
- The Impact of Role of Pharmacists in Renal Dosage Adjustment Program on Renal Drug Dosing Errors: A Quasi-Experimental Study
- Efficacy of nivolumab four-weekly dosing schedule based on body weight
- Approaches to maintenance dosing during oral immunotherapy
- Accurate Dosing Weight: When the 10% Really Matters
- Adherence to Label and Device Recommendations for Over-the-Counter Pediatric Liquid Medications
- Dosing Recommendations for Pediatric Patients With Renal Impairment
- Long‐Term Predictions of the Therapeutic Equivalence of Daily and Less Than Daily Alendronate Dosing
- Research about Method to Improve the Teaching Effect of Clinical Oncology